Brokers Offer Predictions for Atyr PHARMA Q2 Earnings
Atyr PHARMA INC (NASDAQ:ATYR – Free Report) – Stock analysts at Leerink Partnrs issued their Q2 2025 EPS estimates for Atyr PHARMA in a report released on Wednesday, May 7th. Leerink Partnrs analyst F. Khurshid expects that the company will post earnings per share of ($0.17) for the quarter. Leerink Partnrs currently has a “Strong-Buy” […]
